217 related articles for article (PubMed ID: 30124468)
1. Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.
Li HD; Cuevas I; Zhang M; Lu C; Alam MM; Fu YX; You MJ; Akbay EA; Zhang H; Castrillon DH
J Clin Invest; 2018 Aug; 128(9):4179-4191. PubMed ID: 30124468
[TBL] [Abstract][Full Text] [Related]
2. A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response.
Li HD; Lu C; Zhang H; Hu Q; Zhang J; Cuevas IC; Sahoo SS; Aguilar M; Maurais EG; Zhang S; Wang X; Akbay EA; Li GM; Li B; Koduru P; Ly P; Fu YX; Castrillon DH
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699191
[TBL] [Abstract][Full Text] [Related]
3. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.
Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I
J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
Soriano I; Vazquez E; De Leon N; Bertrand S; Heitzer E; Toumazou S; Bo Z; Palles C; Pai CC; Humphrey TC; Tomlinson I; Cotterill S; Kearsey SE
PLoS Genet; 2021 Jul; 17(7):e1009526. PubMed ID: 34228709
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic mechanisms of cancer-associated DNA polymerase ϵ alleles.
Herzog M; Alonso-Perez E; Salguero I; Warringer J; Adams DJ; Jackson SP; Puddu F
Nucleic Acids Res; 2021 Apr; 49(7):3919-3931. PubMed ID: 33764464
[TBL] [Abstract][Full Text] [Related]
6. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.
Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH
PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149
[TBL] [Abstract][Full Text] [Related]
7. Human Pol ε-dependent replication errors and the influence of mismatch repair on their correction.
Agbor AA; Göksenin AY; LeCompte KG; Hans SH; Pursell ZF
DNA Repair (Amst); 2013 Nov; 12(11):954-63. PubMed ID: 24051051
[TBL] [Abstract][Full Text] [Related]
8. Cancers from Novel
Galati MA; Hodel KP; Gams MS; Sudhaman S; Bridge T; Zahurancik WJ; Ungerleider NA; Park VS; Ercan AB; Joksimovic L; Siddiqui I; Siddaway R; Edwards M; de Borja R; Elshaer D; Chung J; Forster VJ; Nunes NM; Aronson M; Wang X; Ramdas J; Seeley A; Sarosiek T; Dunn GP; Byrd JN; Mordechai O; Durno C; Martin A; Shlien A; Bouffet E; Suo Z; Jackson JG; Hawkins CE; Guidos CJ; Pursell ZF; Tabori U
Cancer Res; 2020 Dec; 80(24):5606-5618. PubMed ID: 32938641
[No Abstract] [Full Text] [Related]
9. A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme.
Xing X; Kane DP; Bulock CR; Moore EA; Sharma S; Chabes A; Shcherbakova PV
Nat Commun; 2019 Jan; 10(1):374. PubMed ID: 30670691
[TBL] [Abstract][Full Text] [Related]
10. Polymerase epsilon mutations and concomitant β2-microglobulin mutations in cancer.
Voutsadakis IA
Gene; 2018 Mar; 647():31-38. PubMed ID: 29320758
[TBL] [Abstract][Full Text] [Related]
11. POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status.
Hodel KP; Sun MJS; Ungerleider N; Park VS; Williams LG; Bauer DL; Immethun VE; Wang J; Suo Z; Lu H; McLachlan JB; Pursell ZF
Mol Cell; 2020 Jun; 78(6):1166-1177.e6. PubMed ID: 32497495
[TBL] [Abstract][Full Text] [Related]
12. Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient.
Yamaguchi K; Shimizu E; Yamaguchi R; Imoto S; Komura M; Hatakeyama S; Noguchi R; Takane K; Ikenoue T; Gohda Y; Yano H; Miyano S; Furukawa Y
J Hum Genet; 2019 Aug; 64(8):729-740. PubMed ID: 31089268
[TBL] [Abstract][Full Text] [Related]
13. High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.
Hühns M; Nürnberg S; Kandashwamy KK; Maletzki C; Bauer P; Prall F
Mod Pathol; 2020 Jun; 33(6):1220-1231. PubMed ID: 31857678
[TBL] [Abstract][Full Text] [Related]
14. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
Ahn SM; Ansari AA; Kim J; Kim D; Chun SM; Kim J; Kim TW; Park I; Yu CS; Jang SJ
Oncotarget; 2016 Oct; 7(42):68638-68649. PubMed ID: 27612425
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP
Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations.
Hatakeyama K; Ohshima K; Nagashima T; Ohnami S; Ohnami S; Serizawa M; Shimoda Y; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Sci Rep; 2018 Jun; 8(1):8700. PubMed ID: 29880869
[TBL] [Abstract][Full Text] [Related]
17. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Treatment for
Van Gool IC; Rayner E; Osse EM; Nout RA; Creutzberg CL; Tomlinson IPM; Church DN; Smit VTHBM; de Wind N; Bosse T; Drost M
Clin Cancer Res; 2018 Jul; 24(13):3197-3203. PubMed ID: 29559562
[No Abstract] [Full Text] [Related]
19. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.
Domingo E; Freeman-Mills L; Rayner E; Glaire M; Briggs S; Vermeulen L; Fessler E; Medema JP; Boot A; Morreau H; van Wezel T; Liefers GJ; Lothe RA; Danielsen SA; Sveen A; Nesbakken A; Zlobec I; Lugli A; Koelzer VH; Berger MD; Castellví-Bel S; Muñoz J; ; de Bruyn M; Nijman HW; Novelli M; Lawson K; Oukrif D; Frangou E; Dutton P; Tejpar S; Delorenzi M; Kerr R; Kerr D; Tomlinson I; Church DN
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):207-216. PubMed ID: 28404093
[TBL] [Abstract][Full Text] [Related]
20. Characterization of POLE c.1373A > T p.(Tyr458Phe), causing high cancer risk.
Rocque MJ; Leipart V; Kumar Singh A; Mur P; Olsen MF; Engebretsen LF; Martin-Ramos E; Aligué R; Sætrom P; Valle L; Drabløs F; Otterlei M; Sjursen W
Mol Genet Genomics; 2023 May; 298(3):555-566. PubMed ID: 36856825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
